Edition:
United States

Smith & Nephew PLC (SNN.N)

SNN.N on New York Stock Exchange

35.18USD
23 Jun 2017
Change (% chg)

$-0.22 (-0.62%)
Prev Close
$35.40
Open
$35.50
Day's High
$35.50
Day's Low
$35.13
Volume
119,245
Avg. Vol
114,322
52-wk High
$35.82
52-wk Low
$26.97

SNN.N

Chart for SNN.N

About

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $15,189.90
Shares Outstanding(Mil.): 437.49
Dividend: 0.37
Yield (%): 2.83

Financials

  SNN.N Industry Sector
P/E (TTM): 20.03 34.18 19.01
EPS (TTM): 1.76 -- --
ROI: 13.27 13.01 -5.03
ROE: 19.79 15.52 -4.28

RPT-UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

LONDON, May 5 Shares in Smith & Nephew rose to a nine-month high on Friday after the artificial hip and knee maker said a strong first quarter, led by growth in emerging markets, put it on track to meet it targets for the year.

May 05 2017

UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

* Shares rise to nine-month highs (Adds CEO comments, analyst reaction, shares)

May 05 2017

Smith & Nephew says M&A 'not at top of agenda' at the moment

LONDON The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.

May 05 2017

Smith & Nephew says M&A 'not at top of agenda' at the moment

LONDON, May 5 The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.

May 05 2017

Smith & Nephew Q1 revenue rises 3 pct on underlying basis

LONDON, May 5 Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 3 percent rise in underlying revenue in its first quarter, helped by a return to double-digit growth in emerging markets and a solid performance in knee implants.

May 05 2017

BRIEF-Smith & Nephew signs agreement to distribute Leaf Healthcare technology

* Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure injury technology Source text for Eikon: Further company coverage:

Feb 22 2017

Smith & Nephew hurt by tough markets in China, Gulf states

LONDON Smith & Nephew , Europe's biggest artificial hip and knee maker, reported a 7 percent drop in full-year trading profit, missing average analysts' forecasts, as tough market conditions in China and Saudi Arabia kept growth in check.

Feb 09 2017

UPDATE 2-Smith & Nephew hurt by tough markets in China and Gulf states

* Shares down 2.4 pct (Adds CEO comments, further analyst reaction, updates shares)

Feb 09 2017

Falls in Smith & Nephew, miners weigh on Britain's FTSE

LONDON, Feb 9 Britain's top share index steadied on Thursday as falls among mining stocks weighed, while Smith & Nephew dropped after posting disappointing results.

Feb 09 2017

Smith & Nephew hit by tough markets in China, Gulf States

LONDON, Feb 9 Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 7 percent drop in full-year trading profit, missing average forecasts, as tough market conditions in China and the Gulf States kept growth in check.

Feb 09 2017

More From Around the Web

Competitors

Earnings vs. Estimates